The Texas A&M University System
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1871-04-17
- Employees
- 251
- Market Cap
- -
- Website
- http://www.tamu.edu
Clinical Trials
113
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (98 trials with phase data)• Click on a phase to view related trials
An Interactive Mobile Health (mHealth) App as Intervention for High Anxiety and Depression in College Students
- Conditions
- AnxietyStressDepression - Major Depressive Disorder
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Texas A&M University
- Target Recruit Count
- 125
- Registration Number
- NCT07017569
- Locations
- 🇺🇸
Texas A&M University, College Station, Texas, United States
An Integrative, Digital Health Approach to Veteran-Centered PTSD Care
- Conditions
- PTSD - Post Traumatic Stress DisorderDepression/Anxiety
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Texas A&M University
- Target Recruit Count
- 36
- Registration Number
- NCT06993012
- Locations
- 🇺🇸
Texas A&M University, College Station, Texas, United States
The Neighborhood & Health Study
- Conditions
- Healthy EatingCardiometabolic Health
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Texas A&M University
- Target Recruit Count
- 600
- Registration Number
- NCT06950775
- Locations
- 🇺🇸
Elyson Neighborhood, Katy, Texas, United States
🇺🇸Indigo Neighborhood, Richmond, Texas, United States
Effectiveness of Scaling and Root Planing in Deeper Pockets
- Conditions
- Periodontal DiseasePeriodontitis
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Texas A&M University
- Target Recruit Count
- 110
- Registration Number
- NCT06890689
- Locations
- 🇺🇸
Texas A&M University Collage of Dentistry,, Dallas, Texas, United States
TREC@TAMU Cancer Prevention Registry and Repository
- Conditions
- CancerGeneticsDiseaseDietLifestyle Factors
- First Posted Date
- 2025-02-13
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Texas A&M University
- Target Recruit Count
- 2500
- Registration Number
- NCT06826014
- Locations
- 🇺🇸
Texas A&M Family Care, Bryan, Texas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 23
- Next
News
Texas A&M Researcher's Umbilical Cord Cell Therapy Shows Promise for ALS Treatment in Clinical Trials
Dr. Simrit Parmar at Texas A&M University has developed an innovative umbilical cord blood-derived T regulatory cell therapy that has demonstrated safety and efficacy in treating over 80 patients with ALS and other inflammatory diseases.
PMWC 2025 to Address Key Challenges in Pharmacogenomics Implementation and Access
Leading pharmacogenomics expert Dr. Sara Rogers highlights PMWC 2025's focus on addressing critical barriers to PGx adoption, including insurance coverage and clinical implementation strategies.
HMB Supplementation Shows Promise in Duchenne Muscular Dystrophy Dogs, Improving Activity and Protein Metabolism
A double-blind, placebo-controlled study reveals that beta-hydroxy-beta-methylbutyrate (HMB) supplementation significantly increased physical activity by 40% in dogs with Duchenne Muscular Dystrophy (DMD).
Molecular Jackhammers: Near-Infrared Light Therapy Eradicates Cancer Cells in Lab Studies
Researchers have developed a novel cancer therapy using near-infrared light to induce molecular vibrations that rupture cancer cell membranes.